Searched for
GENERIC CONTRACEPTIVE DRUG
Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...- Lupin launches generic contraceptive drug in USDrug maker Lupin On Thursday said it has launched Merzee capsules, a medication used to prevent pregnancy, in the US market. The Mumbai-bas...
- Lupin gets USFDA approval for generic contraceptive drugThe company has received final approval from the USFDA to market its product which is a generic version of Bayer HealthCare Pharmaceutical ...
- Lupin launches generic oral contraceptive tablets in USDrug major Lupin has launched its Tri-Lo-Marzia tablets, an oral contraceptive drug, in the US market after getting approval from the Ameri...
- Lupin gets FDA nod for generic Aricept tabletsLupin said it has received final approval from the US drug regulator to market generic Aricept tablets used for treatment of dementia.
- Glenmark gets USFDA final nod for contraceptive tabletsThe approval marks the company's 12th oral contraceptive and 2nd extended-cycle oral contraceptive authorised for distribution by the USFDA.
- Lupin gets USFDA nod for oral contraceptive drugLupin said it has received US health regulator's approval to market generic version of Ortho-Novum tablets in the American market.
- Oral Contraceptives Booster to Lupin's US businessAs per the IMS data, the total sales for branded and generic sales for the product stood at $ 361 million for the year ended December 2012.
- Favourable ruling for generic Yaz in US court, says LupinDrug major Lupin today said a US court has ruled in its favour paving the way for the company to introduce a generic version of Bayer AG's ...
- Lupin gets US nod for 7th oral contraceptiveLupin said that it has received final approval from the US health regulator to sell its generic oral contraceptive Levonorgestrel and Ethin...
- Lupin gets USFDA nod to market generic contraceptive tabletsDrug firm Lupin today said it has received final approval from the US health regulator to market its generic Levonorgestrel and Ethinyl Est...
- Lupin gets USFDA approval for oral contraceptive tablets KurveloDrug firm Lupin today said its subsidiary has received American health regulator's approval to market its generic oral contraceptive tablet...
- Glenmark receives ANDA approval for its contraceptive pillsGlenmark Generics Inc., USA, a subsidiary of Glenmark Glenmark on Monday announced they have been granted final approval for their abbrevia...
- Lupin eyes $150 mn from oral contraceptives in US by FY14Drug firm Lupin is expecting revenues of up to USD 150 million (over Rs 780 crore) from its oral contraceptive (OC) segment in the US marke...
- Lupin gets USFDA nod for generic oral contraceptive tabletsLupin has received approval from USFDA to sell 'LoSeasonique' tablets, an oral contraceptive drug, in the American mkt.
- Glenmark unit bags USFDA nod for generic contraceptive drugGlenmark Pharmaceuticals today said it has received health regulator's nod to market and distribute generic contraceptive pills, Norethindr...
- Lupin can't sell pill in US, Teva files patent suitIsraeli drugmaker Teva Pharma has filed a patent infringement suit in the US against Lupin that prevents the Indian pharma company from sel...
- Lupin eyes $200 mn opportunity in US contraceptives marketMumbai-based pharmaceutical firm Lupin is gearing to tap opportunities to the tune of up to $200 million in the US oral contraceptives mark...
- Mylan in talks to pick up 15 pc in Famy CareMylan, the third-largest generic drug maker globally, is in advanced stages of talks to pick up around 15 per cent stake in Famy Care, Indi...
- Teva to buy Barr Pharma for $7.5 bnIn the latest drug consolidation, Teva Pharmaceutical said on Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7...
Load More
